ARTICLES REFERENCED ON "PUBMED" to Ashford JW
- some PDF
files available (7/22/2002) (47 references)
Teter
B, Ashford JW.
Neuroplasticity in Alzheimer's disease.
J Neurosci Res.
2002 Nov 1;70(3):402-37. PDF
Ashford
JW, Mortimer JA.
Non-familial Alzheimer's disease is mainly due to
genetic factors.
J Alzheimers Dis. 2002 Jun;4(3):169-77. PDF
Ashford
JW.
ApoE4: is it the absence of good or the presence of bad?
J
Alzheimers Dis. 2002 Jun;4(3):141-3. No abstract available. PDF
Ashford
JW, Schmitt FA.
Modeling the time-course of Alzheimer dementia.
Curr
Psychiatry Rep. 2001 Feb;3(1):20-8. PDF
Schmitt
FA, Davis DG, Wekstein DR, Smith CD, Ashford JW, Markesbery WR. Preclinical"
AD revisited: neuropathology of cognitively normal older adults.
Neurology.
2000 Aug 8;55(3):370-6. PDF
Mendiondo
MS, Ashford JW, Kryscio RJ, Schmitt FA. Modelling mini mental state
examination changes in Alzheimer's disease.
Stat Med. 2000 Jun
15-30;19(11-12):1607-16. PDF
Ashford
JW, Shih WJ, Coupal J, Shetty R, Schneider A, Cool C, Aleem A, Kiefer VH,
Mendiondo MS, Schmitt FA. Single SPECT measures of cerebral cortical
perfusion reflect time-index estimation of dementia severity in Alzheimer's
disease.
J Nucl Med. 2000 Jan;41(1):57-64.
Shih
WJ, Ashford JW, Coupal JJ, Ryo YU, Stipp V V, Magoun SL, Gross K.
Consecutive brain SPECT surface three-dimensional displays show progression of
cerebral cortical abnormalities in Alzheimer's disease
Clin Nucl Med. 1999
Oct;24(10):773-7.
Shih
WJ, Wilson D, Stipp V, Ashford JW.Heterogenous uptake on brain
SPECT.
Semin Nucl Med. 1999 Jan;29(1):85-8. No abstract available.
Ashford
JW, Soultanian NS, Zhang SX, Geddes JW. Neuropil threads are collinear with
MAP2 immunostaining in neuronal dendrites of Alzheimer brain.
J Neuropathol
Exp Neurol. 1998 Oct;57(10):972-8.
Piecoro
LT, Wermeling DP, Schmitt FA, Ashford JW. Seizures in patients receiving
concomitant antimuscarinics and acetylcholinesterase
inhibitor.
Pharmacotherapy. 1998 Sep-Oct;18(5):1129-32.
Pettigrew
LC, Bieber F, Lettieri J, Wermeling DP, Schmitt FA, Tikhtman AJ, Ashford JW,
Smith CD, Wekstein DR, Markesbery WR, Orazem J, Ruzicka BB, Mas J, Gulanski
B. Pharmacokinetics, pharmacodynamics, and safety of metrifonate in patients
with Alzheimer's disease.
J Clin Pharmacol. 1998 Mar;38(3):236-45.
Shih
WJ, Davis DG, Stipp V, Ashford W, Magoun S. Bilateral perfusion
defect/hypoperfusion in temporal and parietal regions on brain SPECT.
Semin
Nucl Med. 1998 Apr;28(2):192-3. No abstract available.
Schmitt
FA, Ashford W, Ernesto C, Saxton J, Schneider LS, Clark CM, Ferris SH, Mackell
JA, Schafer K, Thal LJ. The severe impairment battery: concurrent validity
and the assessment of longitudinal change in Alzheimer's disease. The
Alzheimer's Disease Cooperative Study.
Alzheimer Dis Assoc Disord. 1997;11
Suppl 2:S51-6.
Geddes
JW, Tekirian TL, Soultanian NS, Ashford JW, Davis DG, Markesbery WR.
Comparison of neuropathologic criteria for the diagnosis of Alzheimer's
disease.
Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S99-105. PDF
Butler
SM, Ashford JW, Snowdon DA. Age, education, and changes in the Mini-Mental
State Exam scores of older women: findings from the Nun Study.
J Am Geriatr
Soc. 1996 Jun;44(6):675-81.
Ashford
JW, Shan M, Butler S, Rajasekar A, Schmitt FA. Temporal quantification of
Alzheimer's disease severity: 'time index' model.
Dementia. 1995
Sep-Oct;6(5):269-80.
Semla
TP, Cohen D, Freels S, Paveza GJ, Ashford JW, Gorelick P, Luchins D, Eisdorfer
C. Psychotropic drug use in relation to psychiatric symptoms in
community-living persons with Alzheimer's disease.
Pharmacotherapy. 1995
Jul-Aug;15(4):495-501.
Smith
CJ, Lippiello PM, Ashford JW. Smoking, Alzheimer's disease, and confounding
with genes.
Lancet. 1995 Apr 22;345(8956):1054. No abstract available.
Mark
RJ, Ashford JW, Goodman Y, Mattson MP. Anticonvulsants attenuate amyloid
beta-peptide neurotoxicity, Ca2+ deregulation, and cytoskeletal
pathology.
Neurobiol Aging. 1995 Mar-Apr;16(2):187-98.
Cohen
D, Eisdorfer C, Gorelick P, Paveza G, Luchins DJ, Freels S, Ashford JW, Semla T,
Levy P, Hirschman R. Psychopathology associated with Alzheimer's disease and
related disorders.
J Gerontol. 1993 Nov;48(6):M255-60.
Coburn
KL, Ashford JW, Moreno MA. Delayed late component of visual global field
power in probable Alzheimer's disease.
J Geriatr Psychiatry Neurol. 1993
Apr-Jun;6(2):72-7.
Semla
TP, Cohen D, Paveza G, Eisdorfer C, Gorelick P, Luchins D, Hirschman R, Freels
S, Levy P, Ashford JW, et al. Drug use patterns of persons with Alzheimer's
disease and related disorders living in the community.
J Am Geriatr Soc. 1993
Apr;41(4):408-13.
Cohen
D, Eisdorfer C, Gorelick P, Luchins D, Freels S, Semla T, Paveza G, Shaw H,
Ashford JW. Sex differences in the psychiatric manifestations of Alzheimer's
disease.
J Am Geriatr Soc. 1993 Mar;41(3):229-32.
Hargrave
R, Ashford JW. Phenelzine treatment of depression in Parkinson's
disease.
Am J Psychiatry. 1992 Dec;149(12):1751-2. No abstract available.
Freels
S, Cohen D, Eisdorfer C, Paveza G, Gorelick P, Luchins DJ, Hirschman R, Ashford
JW, Levy P, Semla T, et al. Functional status and clinical findings in
patients with Alzheimer's disease.
J Gerontol. 1992 Nov;47(6):M177-82.
Brewer
GJ, Ashford JW. Human serum stimulates Alzheimer markers in cultured
hippocampal neurons.
J Neurosci Res. 1992 Nov;33(3):355-69.
Paveza
GJ, Cohen D, Eisdorfer C, Freels S, Semla T, Ashford JW, Gorelick P, Hirschman
R, Luchins D, Levy P. Severe family violence and Alzheimer's disease:
prevalence and risk factors.
Gerontologist. 1992 Aug;32(4):493-7.
Luchins
DJ, Cohen D, Hanrahan P, Eisdorfer C, Paveza G, Ashford JW, Gorelick P,
Hirschman R, Freels S, Levy P, et al. Are there clinical differences between
familial and nonfamilial Alzheimer's disease?
Am J Psychiatry. 1992
Aug;149(8):1023-7.
Eisdorfer
C, Cohen D, Paveza GJ, Ashford JW, Luchins DJ, Gorelick PB, Hirschman RS, Freels
SA, Levy PS, Semla TP, et al. An empirical evaluation of the Global
Deterioration Scale for staging Alzheimer's disease.
Am J Psychiatry. 1992
Feb;149(2):190-4.
Ashford
JW, Kumar V, Barringer M, Becker M, Bice J, Ryan N, Vicari S. Assessing
Alzheimer severity with a global clinical scale.
Int Psychogeriatr. 1992
Summer;4(1):55-74.
Coburn
KL, Ashford JW, Moreno MA. Visual evoked potentials in dementia: selective
delay of flash P2 in probable Alzheimer's disease.
J Neuropsychiatry Clin
Neurosci. 1991 Fall;3(4):431-5.
Cohen
D, Paveza G, Levy PS, Ashford JW, Brody JA, Eisdorfer C, Gorelick P, Hirschman
R, Luchins D, Trozzolo T, et al. An Alzheimer's disease patient registry:
the Prototype Alzheimer Collaborative Team (PACT).
Aging (Milano). 1990
Sep;2(3):312-6. No abstract available.
Coburn
KL, Ashford JW, Fuster JM. Visual response latencies in temporal lobe
structures as a function of stimulus information load.
Behav Neurosci. 1990
Feb;104(1):62-73.
Ashford
JW, Kolm P, Colliver JA, Bekian C, Hsu LN. Alzheimer patient evaluation and
the mini-mental state: item characteristic curve analysis.
J Gerontol. 1989
Sep;44(5):P139-46.
Small
GW, Kuhl DE, Riege WH, Fujikawa DG, Ashford JW, Metter EJ, Mazziotta JC.
Cerebral glucose metabolic patterns in Alzheimer's disease. Effect of gender and
age at dementia onset.
Arch Gen Psychiatry. 1989 Jun;46(6):527-32.
Ashford
JW, Sherman KA, Kumar V. Advances in Alzheimer therapy: cholinesterase
inhibitors.
Neurobiol Aging. 1989 Jan-Feb;10(1):99-105.
Parks
RW, Crockett DJ, Tuokko H, Beattie BL, Ashford JW, Coburn KL, Zec RF, Becker RE,
McGeer PL, McGeer EG. Neuropsychological "systems efficiency" and positron
emission tomography.
J Neuropsychiatry Clin Neurosci. 1989
Summer;1(3):269-82. Review.
Small
GW, Kuhl DE, Fujikawa DG, Ashford JW. Clinical characterization of
Alzheimer's disease: reliability of 'age at onset' and a new descriptor, 'age at
shift'.
J Geriatr Psychiatry Neurol. 1988 Oct-Dec;1(4):207-11.
Kumar
V, Smith RC, Sherman KA, Ashford W, Murphy J, Giacobini E, Colliver J.
Cortisol responses to cholinergic drugs in Alzheimer's disease.
Int J Clin
Pharmacol Ther Toxicol. 1988 Oct;26(10):471-6.
Ashford
JW, Fuster JM. Occipital and inferotemporal responses to visual signals in
the monkey.
Exp Neurol. 1985 Nov;90(2):444-66.
Ashford
JW, Coburn KL, Fuster JM. The elgiloy microelectrode: fabrication techniques
and characteristics.
J Neurosci Methods. 1985 Sep;14(4):247-52.
Ashford
JW, Jarvik L. Alzheimer's disease: does neuron plasticity predispose to
axonal neurofibrillary degeneration?
N Engl J Med. 1985 Aug 8;313(6):388-9.
No abstract available.
Fuster
JM, Willey TJ, Riley DM, Ashford JW. Effects of ethanol on visual evoked
responses in monkeys performing a memory task.
Electroencephalogr Clin
Neurophysiol. 1982 Jun;53(6):621-33.
Ashford
JW, Soldinger S, Schaeffer J, Cochran L, Jarvik LF. Physostigmine and its
effect on six patients with dementia.
Am J Psychiatry. 1981
Jun;138(6):829-30. No abstract available.
Ashford
JW, Schulz C, Walsh GO. Violent automatism in a partial complex seizure.
Report of a case.
Arch Neurol. 1980 Feb;37(2):120-2.
Ashford
JW, Ford CV. Use of MAO inhibitors in elderly patients.
Am J Psychiatry.
1979 Nov;136(11):1466-7. No abstract available.